Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(fluorenyl-9-methoxycarbonyl)leucine
2. Npc 15199
3. Npc 15199, (d)-isomer
4. Npc-15199
1. 35661-60-0
2. Fmoc-leu-oh
3. N-fmoc-l-leucine
4. Fmoc-l-leu-oh
5. Fmoc-leucine
6. N-(9-fluorenylmethoxycarbonyl)-l-leucine
7. Npc 15199
8. N-[(9h-fluoren-9-ylmethoxy)carbonyl]-l-leucine
9. (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic Acid
10. Npc-15199
11. N-(fluorenyl-9-methoxycarbonyl)leucine
12. Fmoc-leu
13. (((9h-fluoren-9-yl)methoxy)carbonyl)-l-leucine
14. Mls002695993
15. Kf18f70uf3
16. (s)-2-((((9h-fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic Acid
17. Smr001562137
18. N-((9h-fluoren-9-ylmethoxy)carbonyl)-l-leucine
19. Mfcd00037133
20. (2s)-2-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanoic Acid
21. L-leucine, N-[(9h-fluoren-9-ylmethoxy)carbonyl]-
22. L-leucine, N-((9h-fluoren-9-ylmethoxy)carbonyl)-
23. Unii-kf18f70uf3
24. Fmoc Leucine
25. N-fmoc Leucine
26. Nsc-334290
27. (2s)-2-((((9h-fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic Acid
28. Fmoc-l-leu
29. Einecs 252-662-7
30. Fmoc-l-leu--oh
31. Maybridge1_005562
32. N-.alpha.-fmoc-l-leucine
33. Dsstox_cid_20751
34. Dsstox_rid_79588
35. Dsstox_gsid_40751
36. Divk1c_001850
37. Schembl120560
38. Chembl149394
39. Dtxsid0040751
40. Cid_1549133
41. Fmoc-leu-oh, >=97.0%
42. Hms557e18
43. L-leucine, Fmoc Protected
44. Bdbm115093
45. Act07974
46. Str09711
47. Tox21_301495
48. (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic Acid
49. (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methyl-valeric Acid
50. Stl466197
51. Zinc82067500
52. (2s)-2-[[9h-fluoren-9-ylmethoxy(oxo)methyl]amino]-4-methylpentanoic Acid
53. (2s)-2-{[(9h-fluoren-9-ylmethoxy)carbonyl]amino}-4-methylpentanoic Acid
54. Akos010398974
55. Akos015837135
56. N-9-fluorenylmethoxycarbonyl-l-leucine
57. Ccg-249806
58. Cs-w019808
59. N-(9-fluorenylmethyloxycarbonyl)leucine
60. Nsc 334290
61. Cds1_000810
62. Ncgc00164403-01
63. Ncgc00255677-01
64. Ac-24092
65. N-(fluoren-9-ylmethoxycarbonyl)-l-leucine
66. Cas-35661-60-0
67. Db-038143
68. Hy-101064
69. N-[(9-fluorenyl)methoxycarbonyl]-l-leucine
70. Am20060470
71. F0295
72. N-[(9-fluorenyl)-methoxycarbonyl]-l-leucine
73. D71213
74. M03365
75. N-9-fluorenylmethyloxycarbonyl-l-leucine
76. N-(9-fluorenylmethyloxycarbonyl)-leucine
77. N-[(9h-fluoren-9-ylmethoxy)carbonyl]leucine #
78. 661f600
79. A822928
80. Sr-05000000436
81. Fluoren-9-yl N-(1-carboxy-3-methylbutyl)carbamate
82. J-300159
83. Q-101698
84. Sr-05000000436-2
85. Q27282223
86. N-((9h-fluoren-9-ylmethoxy)carbonyl)-l-leucine, (-)-
87. N-alpha-(9-fluorenylmethyloxycarbonyl)-l-leucine (fmoc-l-leu-oh)
88. (s)-2-(((9h-fluoren-9-yl)methoxy)carbonylamino)-4-methylpentanoic Acid
| Molecular Weight | 353.4 g/mol |
|---|---|
| Molecular Formula | C21H23NO4 |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 353.16270821 g/mol |
| Monoisotopic Mass | 353.16270821 g/mol |
| Topological Polar Surface Area | 75.6 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 484 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 9-Fluorenylmethoxycarbonyl-L-Leucine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 9-Fluorenylmethoxycarbonyl-L-Leucine, including repackagers and relabelers. The FDA regulates 9-Fluorenylmethoxycarbonyl-L-Leucine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 9-Fluorenylmethoxycarbonyl-L-Leucine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 9-Fluorenylmethoxycarbonyl-L-Leucine supplier is an individual or a company that provides 9-Fluorenylmethoxycarbonyl-L-Leucine active pharmaceutical ingredient (API) or 9-Fluorenylmethoxycarbonyl-L-Leucine finished formulations upon request. The 9-Fluorenylmethoxycarbonyl-L-Leucine suppliers may include 9-Fluorenylmethoxycarbonyl-L-Leucine API manufacturers, exporters, distributors and traders.
click here to find a list of 9-Fluorenylmethoxycarbonyl-L-Leucine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 9-Fluorenylmethoxycarbonyl-L-Leucine DMF (Drug Master File) is a document detailing the whole manufacturing process of 9-Fluorenylmethoxycarbonyl-L-Leucine active pharmaceutical ingredient (API) in detail. Different forms of 9-Fluorenylmethoxycarbonyl-L-Leucine DMFs exist exist since differing nations have different regulations, such as 9-Fluorenylmethoxycarbonyl-L-Leucine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 9-Fluorenylmethoxycarbonyl-L-Leucine DMF submitted to regulatory agencies in the US is known as a USDMF. 9-Fluorenylmethoxycarbonyl-L-Leucine USDMF includes data on 9-Fluorenylmethoxycarbonyl-L-Leucine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 9-Fluorenylmethoxycarbonyl-L-Leucine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 9-Fluorenylmethoxycarbonyl-L-Leucine suppliers with USDMF on PharmaCompass.
9-Fluorenylmethoxycarbonyl-L-Leucine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 9-Fluorenylmethoxycarbonyl-L-Leucine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 9-Fluorenylmethoxycarbonyl-L-Leucine GMP manufacturer or 9-Fluorenylmethoxycarbonyl-L-Leucine GMP API supplier for your needs.
A 9-Fluorenylmethoxycarbonyl-L-Leucine CoA (Certificate of Analysis) is a formal document that attests to 9-Fluorenylmethoxycarbonyl-L-Leucine's compliance with 9-Fluorenylmethoxycarbonyl-L-Leucine specifications and serves as a tool for batch-level quality control.
9-Fluorenylmethoxycarbonyl-L-Leucine CoA mostly includes findings from lab analyses of a specific batch. For each 9-Fluorenylmethoxycarbonyl-L-Leucine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
9-Fluorenylmethoxycarbonyl-L-Leucine may be tested according to a variety of international standards, such as European Pharmacopoeia (9-Fluorenylmethoxycarbonyl-L-Leucine EP), 9-Fluorenylmethoxycarbonyl-L-Leucine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (9-Fluorenylmethoxycarbonyl-L-Leucine USP).
LOOKING FOR A SUPPLIER?
